Submitted by Anonymous (not verified) on 10 February 2026 - 14:50
Human medicines European public assessment report (EPAR): Vueway, gadopiclenol, Date of authorisation: 07/12/2023, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vueway, gadopiclenol, Date of authorisation: 07/12/2023, Revision: 4, Status: Authorised